Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

WIPO unveils course on genetic resources in the life sciences
Genetics
The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.   6 May 2021
Novartis withdraws bid to block US Regeneron imports
Americas
Pharmaceutical company Novartis has abandoned its attempt to halt US imports of Regeneron’s Eylea pre-filled syringes amid concerns that such a ban could hinder public access to essential treatments.   4 May 2021
Dr Reddy’s hits Amarin with antitrust suit over Vascepa
Americas
Amarin delayed the market entry of generic versions of the cardiovascular drug Vascepa by using supply agreements to halt competitors from accessing the drug’s active pharmaceutical ingredient, according to a new antitrust lawsuit.   29 April 2021
Americas
In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.   22 April 2021
Americas
L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.   22 April 2021
Americas
Law firm Withers has expanded its US tech practice with the hire of a new team of life sciences and venture capital-focused lawyers in Boston.   20 April 2021
Pharma
Edwards Lifesciences will be able to proceed with its claims of trademark infringement over an artificial heart valve against Meril Life Sciences, according to a US federal court.   13 April 2021
Pharma
The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.   8 April 2021
Americas
Pharmaceutical companies defending an antitrust lawsuit have fought back against attempts to get them to disclose confidential information garnered through discovery during the litigation to the US Federal Trade Commission.   6 April 2021
Americas
The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office.   1 April 2021

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.